subject area of
-
S odium‐glucose co‐transporter‐2 inhibitors are associated with kidney benefits at all degrees of albuminuria: A retrospective cohort study of adults with diabetes Journal Articles - Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes Journal Articles
- Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin Journal Articles
- Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis Journal Articles
- Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert Forum Journal Articles
-
Cardiovascular events and all‐cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs:
A B ayesian meta‐analysis of survival data Journal Articles - Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies Journal Articles
- Dipeptidyl peptidase‐4 inhibitor and insulin combination treatment in type 2 diabetes and chronic kidney disease: A meta‐analysis Journal Articles
- Effects of Incretin-based Therapies on Weight-related Indicators among Patients with Type 2 Diabetes: A Network Meta-analysis. Journal Articles
- Falsely Accused? Insufficient Evidence to Conclude that Sitagliptin is a Cause of Chronic Cough Journal Articles
- Fracture Risk of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease Journal Articles
- GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes Journal Articles
- Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis Journal Articles
- Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study Journal Articles
- Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis Journal Articles
- Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies Journal Articles
- Lowering of hemoglobin A1C and risk of cardiovascular outcomes and all-cause mortality, a meta-regression analysis Journal Articles
- Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis Journal Articles
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Journal Articles
- Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004–2013 Journal Articles
- The dual DPP4 inhibitor and GPR119 agonist HBK001 regulates glycemic control and beta cell function ex and in vivo Journal Articles
- The effects of incretin‐based therapies on β‐cell function and insulin resistance in type 2 diabetes: A systematic review and network meta‐analysis combining 360 trials Journal Articles
- The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes Journal Articles
- Use of sodium–glucose cotransporter-2 inhibitors and risk of acute kidney injury in older adults with diabetes: a population-based cohort study Journal Articles